chitosan has been researched along with ondansetron in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Goel, H; Rana, V; Tiwary, AK; Vora, N | 2 |
Arora, A; Goel, H; Rana, V; Tiwary, AK | 1 |
Baktir, G; Erturk-Toker, S; Gungor, S; Okyar, A; Ozsoy, Y | 1 |
Jee, JP; Kim, CK; Kim, HT; Park, DM; Song, YK | 1 |
Can, AS; Erdal, MS; Güngör, S; Özsoy, Y | 1 |
Mahajan, HS; Sonje, AG | 1 |
Abruzzo, A; Bigucci, F; Cerchiara, T; Dalena, F; Giordani, B; Luppi, B; Nicoletta, FP; Prata, C | 1 |
8 other study(ies) available for chitosan and ondansetron
Article | Year |
---|---|
Understanding the mechanism for paradoxical effect of ionized and unionized chitosan: Orodispersible tablets of Ondansetron Hydrochloride.
Topics: Administration, Oral; Chitosan; Drug Compounding; Glycine; Hardness; Ondansetron; Serotonin Antagonists; Solubility; Tablets | 2009 |
Formulation of orodispersible tablets of ondansetron HCl: investigations using glycine-chitosan mixture as superdisintegrant.
Topics: Antiemetics; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Glycine; Ondansetron; Serotonin Antagonists; Tablets | 2009 |
Development and evaluation of mathematical model to predict disintegration time of fast disintegrating tablets using powder characteristics.
Topics: Adsorption; Chemistry, Pharmaceutical; Chitosan; Compressive Strength; Domperidone; Drug Stability; Excipients; Glycine; Metoclopramide; Models, Chemical; Ondansetron; Powders; Solubility; Tablets; Time Factors; Water | 2011 |
Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
Topics: Administration, Intranasal; Animals; Antiemetics; Biological Availability; Chitosan; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Male; Microspheres; Ondansetron; Particle Size; Rats; Rats, Wistar; Technology, Pharmaceutical | 2010 |
Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis.
Topics: Absorption; Adhesiveness; Administration, Buccal; Animals; Antiemetics; Biological Availability; Chitosan; Cricetinae; Drug Compounding; Excipients; Gels; Half-Life; Male; Mesocricetus; Mouth Mucosa; Ondansetron; Pharmaceutical Vehicles; Serotonin 5-HT3 Receptor Antagonists; Solubility; Vomiting | 2012 |
Optimization and characterization of chitosan films for transdermal delivery of ondansetron.
Topics: Administration, Cutaneous; Animals; Anti-Anxiety Agents; Chitosan; Humans; Ondansetron; Swine; Transdermal Patch | 2013 |
Nasal inserts containing ondansetron hydrochloride based on Chitosan-gellan gum polyelectrolyte complex: In vitro-in vivo studies.
Topics: Animals; Chitosan; Drug Delivery Systems; Nasal Mucosa; Ondansetron; Polyelectrolytes; Polysaccharides, Bacterial; Sheep | 2016 |
Ondansetron buccal administration for paediatric use: A comparison between films and wafers.
Topics: Adhesiveness; Administration, Buccal; Animals; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Chitosan; Dosage Forms; Drug Compounding; Drug Delivery Systems; Freeze Drying; Gelatin; Mouth Mucosa; Ondansetron; Pediatrics; Swine | 2020 |